# Open Label Safety Study of DCI-1020 in Pediatric Cystic Fibrosis (CF) Patients

> **NCT00663975** · NA · WITHDRAWN · sponsor: **Digestive Care, Inc.** · enrollment: 24 (estimated)

## Conditions studied

- Digestive System Diseases
- Pancreatic Disease
- Cystic Fibrosis
- Exocrine Pancreatic Insufficiency

## Interventions

- **DRUG:** DCI 1020

## Key facts

- **NCT ID:** NCT00663975
- **Lead sponsor:** Digestive Care, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-02
- **Primary completion:** 2009-08
- **Final completion:** 2009-11
- **Target enrollment:** 24 (ESTIMATED)
- **Why stopped:** Study not being conducted
- **Last updated:** 2010-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00663975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00663975, "Open Label Safety Study of DCI-1020 in Pediatric Cystic Fibrosis (CF) Patients". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00663975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*